SEVER, B. Et Al. 2021. Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Archiv der Pharmazie , vol.354, no.12 .

SEVER, B., TÜRKEŞ, C., ALTINTOP, M. D., Demir, Y., AKALIN ÇİFTÇİ, G., & BEYDEMİR, Ş., (2021). Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Archiv der Pharmazie , vol.354, no.12.

SEVER, BELGİN Et Al. "Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds," Archiv der Pharmazie , vol.354, no.12, 2021

SEVER, BELGİN Et Al. "Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds." Archiv der Pharmazie , vol.354, no.12, 2021

SEVER, B. Et Al. (2021) . "Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds." Archiv der Pharmazie , vol.354, no.12.

@article{article, author={BELGİN SEVER Et Al. }, title={Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds}, journal={Archiv der Pharmazie}, year=2021}